Vandetanib and Headache - a phase IV clinical study of FDA data

Summary:

Headache is reported as a side effect among people who take Vandetanib (vandetanib), especially for people who are female, 20-29 old, have been taking the drug for < 1 month also take Afinitor, and have Paraganglion neoplasm malignant.

The phase IV clinical study analyzes which people have Headache when taking Vandetanib. It is created by eHealthMe based on reports of 1,030 people who have side effects when taking Vandetanib from the FDA, and is updated regularly.

What is Vandetanib?

Vandetanib has active ingredients of vandetanib. eHealthMe is studying from 1,032 Vandetanib users. Check the latest studies of Vandetanib.

What is Headache?

Headache (pain in head) is found to be associated with 3,751 drugs and 5,772 conditions by eHealthMe. Check the latest studies of Headache.

On Jul, 20, 2026

1,030 people reported to have side effects when taking Vandetanib.
Among them, 51 people (4.95%) have Headache.

Among these 51 people:

How long have people been on Vandetanib when they have Headache? *

What is the gender of people who have Headache when taking Vandetanib? *

female: 80.85 %
male: 19.15 %

What is the age of people who have Headache when taking Vandetanib? *

What are other drugs people take besides Vandetanib? *

What are other side effects people have besides Headache? *

Insomnia (sleeplessness): 25 people, 49.02%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 25 people, 49.02%
Metastases To Central Nervous System (cancer spreads to central nervous system): 20 people, 39.22%
Metastases To Bone (cancer spreads to bone): 19 people, 37.25%
Metastases To Liver (cancer spreads to liver): 19 people, 37.25%
Diarrhea: 16 people, 31.37%
Rashes (redness): 12 people, 23.53%
Dyspnea (difficult or laboured breathing): 11 people, 21.57%
Blood Pressure Abnormal: 10 people, 19.61%
Nausea (feeling of having an urge to vomit): 10 people, 19.61%

What are the existing conditions these people have? *

Paraganglion Neoplasm Malignant (paraganglion cancerous tumour): 25 people, 49.02%
Phaeochromocytoma (vascular tumour of the adrenal gland): 18 people, 35.29%
Thyroid Cancer: 17 people, 33.33%
Medullary Thyroid Cancer (type of thyroid cancer that develops in the parafollicular cells of the thyroid gland): 7 people, 13.73%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 6 people, 11.76%
Diarrhea: 6 people, 11.76%
Blood Calcium Decreased: 6 people, 11.76%
Phaeochromocytoma Malignant (cancer of the adrenal gland): 5 people, 9.80%
Urinary Tract Infection: 1 person, 1.96%
Thyroid Cancer Stage Iv (the thyroid cancer has grown outside the thyroid): 1 person, 1.96%

* Approximation only. Some reports may have incomplete information.

Do you take Vandetanib and have Headache?

- Check whether Headache is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vandetanib:

Vandetanib (1,032 reports)

Headache treatments and more:

Headache (756,642 reports)

Browse all side effects of Vandetanib:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Headache:

Headache (3,751 drugs)

Browse all the conditions that are associated with Headache:

Headache (5,772 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on vandetanib (the active ingredients of Vandetanib) and Vandetanib (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.